Medical Cannabis News


Cannabis and psychosis: New research


Solving the puzzle of whether cannabis is associated with, or causes, psychosis.

A recent issue of the American Journal of Psychiatry (January 1, 2022) contained new research data and an incisive editorial that advances our understanding of whether cannabis can cause, or is merely associated with, psychosis.

The association of cannabis with psychosis was first noted by the Scottish psychiatrist Thomas Clouston after visiting the Cairo asylum in 1896, where 40 out of the 253 patients had insanity attributed to hashish. Studies since then have conclusively documented cannabis’s association with schizophrenia-like psychosis.


Australian Firm To Launch Clinical Trial In UK On Efficacy Of Cannabis To Cure Long COVID

cannabis plant

The UK has approved Australia‚Äôs medicinal cannabis company Bod Australia‚Äôs clinical trial into the efficacy of its products to treat the effects of long-COVID-19.¬† According to¬†Business News Australia¬†report, Bod announced that it received Clinical Trial Austgorisation by UK‚Äôs UK‚Äôs Medicines & Healthcare Products Regulatory Agency which would allow the company to commence a clinical trial into the effectiveness of its ‚ÄėMediCabilis‚Äô 5% CBD product on long-COVID-19.¬†


More Canadians seeking help for cannabis addictions

smoking a joint

At the onset of the pandemic, millions of people found themselves stuck at home, working, taking care of children and older family members, or simply abiding by restrictions and lockdowns due to the then-newness of COVID-19.

While the situation had many benefits ‚ÄĒ albeit, along with many stresses ‚ÄĒ there was a dangerous downside for those who suffer from substance use disorders or grapple with mental health issues.


Cannabis compounds, as complement to vaccines, can prevent coronavirus from entering human cells, study says

corona virus

Could cannabis really help prevent a positive coronavirus outcome? A new study published by researchers at Oregon State University found that hemp compounds have the ability to prevent the virus from entering human cells, according to a report from New4JAX sister station WDIV in Detroit.

The researchers were investigating small-molecule therapeutic agents, which in addition to vaccines, might help treat or prevent infections by SARS-CoV-2 and its variants, which cause COVID-19.

The study said that cannabinoid acids from hemp (Cannabis sativa) bind to the COVID spike protein, blocking a critical step in the process the virus uses to infect people and preventing the entry of live SARS-CoV-2 into cells.


Ontario saw nine times more ER visits for cannabis poisonings in kids after legalization


A new study has found that Ontario saw nine times more emergency department visits per month for cannabis poisonings in young children after Canada legalized recreational cannabis.

The study, published Friday in JAMA Network Open, found that there were "more frequent and severe" emergency department (ED) visits in the province due to cannabis poisoning in children under the age of 10 following legalization, with the largest increase seen after commercial cannabis edibles hit the market.

While individual hospitals have reported on child cannabis poisonings before, researchers say this is the first study to look at the data for an entire region.


Regular Marijuana Use May Lead to Sleep Problems


A new study found that frequent intake of cannabis may increase the likelihood a person will sleep too little or too much.

Although some people turn to cannabis as a sleep aid because it makes them drowsy and relaxed, a large new study shows that marijuana may interfere with proper rest, especially if you’re a heavy user.


Why do people use cannabis during pregnancy and breastfeeding?

pregnant woman

People who use cannabis during pregnancy and lactation choose it to manage pregnancy-related symptoms and pre-existing conditions, such as nausea and vomiting, mental health problems, insomnia and more, according to new research published in CMAJ (Canadian Medical Association Journal).


Australia Rejects Psychedelics for Therapeutic Use



Counter to the overall trend in support of psychedelic research, Australia will not approve psychedelics for therapeutic use.

Australia’s medical regulator on Wednesday rejected a bid to approve psychedelics for therapeutic use, saying the risks of the drugs outweigh the potential mental health benefits. In a final decision from the Therapeutic Goods Administration (TGA), the agency declined to approve an application to amend Australia’s poison standards by reclassifying psilocybin and MDMA as Schedule 8 controlled substances instead of their current status as prohibited substances under Schedule 9.


"The New Cannabis" ‚Äď the present and future of psilocybin as a medical treatment in Canada

gloved hand

WeirFoulds' Dana Kriszenfeld on loosening the regulations on psychedelic mushrooms' main ingredient

Psilocybin is the active ingredient found in magic mushrooms, which many refer to as the "new cannabis". As interest in this substance grows, Canada’s capital markets have seen an increase in activity related to psilocybin from both public companies and investors. Proponents cite research demonstrating psilocybin’s potential as a treatment for various mental illnesses. While the research in this area is optimistic, psilocybin remains a heavily regulated substance in Canada. Here, we outline the current situation in Canada for psilocybin and offer thoughts on the future of this emerging industry. 


Strange Side Effects of Marijuana, Says Science

old woman smoking up

According to medical experts, the following side effects can happen when smoking marijuana.


Subscribe to RSS - Medical Cannabis News